New findings in glioblastoma treatment: bavituximab combined with chemoradiotherapy demonstrated encouraging survival and reduced tumor immunosuppression, with biomarkers that may help identify responders.
AbstractPurpose:. We evaluated the efficacy of bavituximab—a mAb with anti-angiogenic and immunomodulatory properties—in newly diagnosed patients with glioblastoma (GBM) who also received radiotherapy...
